NAKA Kindly MD, Inc.

Nasdaq kindlymd.com


$ 0.97 $ 0.00 (0 %)    

Monday, 27-Oct-2025 05:49:15 EDT
QQQ $ 624.99 $ 0.00 (0 %)
DIA $ 474.94 $ 0.00 (0 %)
SPY $ 683.09 $ 0.00 (0 %)
TLT $ 91.09 $ 0.00 (0 %)
GLD $ 372.28 $ 0.00 (0 %)
$ 0.84
$ 0.80
$ 0.97 x 1,400
$ 0.98 x 3
-- - --
$ 0.65 - $ 34.77
29,985,304
na
6.39M
$ 5.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 06-27-2024 03-31-2024 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

B. Riley Securities analyst Fedor Shabalin initiates coverage on Kindly MD (NASDAQ:NAKA) with a Buy rating and announces Pri...

Core News & Articles

First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasur...

Core News & Articles

First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasur...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

 anthony-scaramucci-says-all-will-be-well-amid-naka-stock-volatility-david-bailey-admits-investors-are-down-money

Anthony Scaramucci, the founder and managing partner of SkyBridge Capital, lent support to David Bailey on Tuesday, whose newly...

Core News & Articles

On September 15, 2025, Kindly MD, Inc., a Utah corporation (the "Company") issued a notice of redemption ("Redempti...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION